Ketoconazole Foam 2% for the Treatment of Versicolor

Completed · Phase 4

Conditions studied: Tinea Versicolor

In brief

Ten adult patients age 19 and older with a clinical diagnosis of tinea versicolor, as well as a positive Potassium Hydroxide (KOH) using calcofluor. Ketoconazole 2% foam will be used to determine its effectiveness, safety and satisfaction when used to treat tinea versicolor.

Key facts

Study ID

NCT00830388

Run by

Boni Elewski, MD

People needed

11

Starts

2008-11-01

Expected to finish

2010-09-01

Last updated by the study team

2012-08-22

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or female patients, aged 19 years and over.
• Clinical presentation of tinea versicolor.
• Positive KOH using calcofluor.
• The ability to provide informed consent (including photography release)

You may not qualify if…

• Use of topical antifungal to the affected area in the past 30 days
• Use of topical steroid to the affected area in the past 14 days
• If female, positive urine pregnancy test at screening (female patients of childbearing potential must be practicing a reliable method of birth control, not be planning a pregnancy, not be breast-feeding during the study)
• Patients with a dermatologic condition in the region of the treatment site that in the investigator's opinion may interfere with the study results
• Current diagnosis of immunocompromising conditions
• Any medical or psychiatric condition that may interfere with treatment or compliance

Where it is running

• UAB Dermatology — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.